Clinical Trials · NCT07539415
A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers
- Phase
- Phase 1
- Recruitment status
- Recruiting
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Enrollment
- 72
- Start date
- May 2026
- Locations
- 1 site, South Korea
- Primary endpoint
- AUC 0-t